Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Non Operating Income of -$5.3 million for Q1 2026, up 80.88% sequentially from -$27.5 million in Q4 2025, and down 888.61% YoY from $667000.0 in Q1 2025.
Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Non Operating Income for 4 years, with the latest figure at -$5.3 million in Q1 2026.
- Quarterly Non Operating Income fell 888.61% year-over-year to -$5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.8 million (down 2293.18% YoY) and the FY2025 annual result came in at -$27.8 million, down 2247.11% from the prior year.
- Non Operating Income improved to -$5.3 million in Q1 2026 per CAMP's latest filing, from -$27.5 million in the prior quarter.
- Over five years, Non Operating Income peaked at $755000.0 in Q4 2024 and troughed at -$27.5 million in Q4 2025.
- A 4-year average of -$2.8 million and a median of $423000.0 in 2024 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 412.79% in 2025, down 4625.0% in 2025.
- Over 4 years, Non Operating Income stood at $486000.0 in 2023, then surged by 55.35% to $755000.0 in 2024, then plunged by 3743.44% to -$27.5 million in 2025, then soared by 80.88% to -$5.3 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$5.3 million, -$27.5 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -20.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.15 Mn |
| Mar 31, 2026 | -5.26 Mn |
| Dec 31, 2025 | -27.51 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 642,000.00 |